DCDQ
DCDQ is a potent acetylcholinesterase (AChE) inhibitor. DCDQ shows a strong binding affinity with the 4EY7 protein (binding energy: −8.2 kcal/mol) . DCDQ is promising for research of Alzheimer's disease (AD) [1].
Product Specifications
CAS Number
27631-29-4
UNSPSC
12352005
Target
Cholinesterase (ChE)
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Purity
99.94
Solubility
DMSO : 16.67 mg/mL (ultrasonic)
Smiles
ClC1=NC2=C(C=C(C(OC)=C2)OC)C(Cl)=N1
Molecular Formula
C10H8Cl2N2O2
Molecular Weight
259.09
References & Citations
[1]Asokan K, et al. Spectroscopic, DFT, In Silico, and Estimation of Biological Activity of 2, 4‐Dichloro‐6, 7‐Dimethoxyquinazoline as a Potential Anti‐Alzheimer's Disease Therapeutic Agent[J]. International Journal of Quantum Chemistry, 2025, 125 (1) : e70006.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2044927-01 0.1 mL
APC-Linked Polyclonal Antibody to Orexin A (OXA)
Sign In for Pricing
View Details MBS2044927-02 0.2 mL
APC-Linked Polyclonal Antibody to Orexin A (OXA)
Sign In for Pricing
View Details